What is the mechanism of action of Venetoclax?

Venetoclax/Venetoclax (Venetoclax) is a type of B cell lymphoma pan>/Leukemia-2 (BCL-2) inhibitor, its mechanism of action mainly involves the regulation of apoptosis (programmed cell death). Apoptosis is a physiological process of cell self-destruction that is essential for maintaining normal tissue structure and function. However, in some diseases, especially leukemias and lymphomas, the regulation of apoptosis may be imbalanced, leading to uncontrolled proliferation and survival of malignant cells.

BCL-2 is a key anti-apoptotic protein that can inhibit the apoptotic process. In some tumors, BCL-2 is overexpressed, allowing cancer cells to escape the normal apoptosis mechanism, leading to their abnormal survival and proliferation.

The mechanism of action of venetoclax/venetoclax is to block its inhibitory effect on apoptosis by specifically binding and inhibiting the BCL-2 protein. In this way, venetoclax causes cancerous cells to undergo programmed cell death, thereby reducing the number of abnormal cells and controlling tumor growth and spread.

The targeted nature of this mechanism of action makesvenetoclax/venetoclax an innovative therapeutic drug, especially suitable for span>BCL-2overexpression of chronic lymphocytic leukemia (CLL) and other B cell lymphomas. The introduction of Venetoclax/Venetoclax provides new treatment options for some patients, especially those who are resistant to traditional treatments, and opens up new avenues for the treatment of hematological malignancies. However, using Venecla/Venetoclaxstill requires close collaboration between patients and doctors to ensure effective treatment and minimize potential side effects.

Venetoclax/Venetoclax has been launched in China and has been included in medical insurance, and patients can purchase it domestically. Specifications: 100mg*14tablets and the price is around 5,000yuan. Please consult the local hospital pharmacy for specific prices. There are original drugs and generic drugs abroad. The Turkish version of Venetoclax/Venetoclaxoriginal drug on the market overseas, specification: 100mg*112 tablets, costs about 10,000 per box. Foreign generic drugs are relatively cheaper. For example, the generic drugs sold in Laos and Bangladesh are priced at about more than 4,000 yuan for 100mg*120 tablets. The ingredients of original drugs and generic drugs are basically the same.